{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:07:46Z","timestamp":1793308066245,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7222302"],"award-info":[{"award-number":["7222302"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071875"],"award-info":[{"award-number":["82071875"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2021YFF0501400"],"award-info":[{"award-number":["2021YFF0501400"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To assess the prognostic value of multiple late gadolinium enhancement (LGE) quantification methods for sudden cardiac death (SCD) prediction in hypertrophic cardiomyopathy (HCM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      In this single-center retrospective study, 617 HCM patients who underwent cardiac magnetic resonance (CMR) examinations were consecutively enrolled. LGE was quantified using the\n                      <jats:italic>n<\/jats:italic>\n                      -standard deviation (SD) technique (with multiple thresholds) and the full width at half maximum method. \u201cGray zone\u201d was defined as the myocardium with signal intensity between two predefined thresholds on LGE images. The primary outcome was SCD or aborted SCD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 617 HCM patients, 424 (68.7%) were male, mean age was 49.1\u2009\u00b1\u200914.0 years, and LGE was identified in 438 (71.0%). During 67.9\u2009\u00b1\u200921.0 months of follow-up, 24 patients (3.9%) reached the primary endpoint. All dual-threshold gray zone measures and five single-threshold LGE quantifications (2\u20136 SDs) independently predicted SCD (HR range: 1.031\u20131.220, all adjusted\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Gray zone (HR range: 1.091\u20131.220) showed stronger associations than single-threshold LGE measures (HR range: 1.031\u20131.046). Both approaches improved discrimination beyond the composite American Heart Association (AHA)\/American College of Cardiology (ACC) model, with increased net reclassification improvement (0.321 and 0.397, respectively) and comparable C-statistics (0.794\u20130.871 vs 0.794\u20130.898,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.155).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>While conventional single-threshold LGE quantification predicts SCD in HCM, dual-threshold gray-zone analysis demonstrates stronger associations. Both approaches provide incremental prognostic value beyond the AHA\/ACC guideline-based risk model. These findings underscore the importance of standardizing LGE quantification to improve SCD risk stratification in patients with HCM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:bold>Question:<\/jats:bold>\n                            The optimal LGE quantification approach for SCD risk stratification in HCM remains uncertain.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:bold>Findings:<\/jats:bold>\n                            Both single- and dual-threshold LGE quantification independently predict SCD in patients with HCM, while dual-threshold gray zone metrics demonstrate stronger prognostic associations.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:bold>Critical Relevance:<\/jats:bold>\n                            By systematically comparing multiple LGE quantification approaches, this study highlights the impact of methodological variability on SCD risk stratification in HCM, underscores the need for standardized LGE assessment, and informs clinical radiology practice.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13244-026-02385-3","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:47:30Z","timestamp":1787752050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Enhancing risk prediction for sudden cardiac death: quantitative late gadolinium enhancement analysis in hypertrophic cardiomyopathy"],"prefix":"10.1186","volume":"17","author":[{"given":"Lili","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0619-6038","authenticated-orcid":false,"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"2385_CR1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1056\/NEJMra1710575","volume":"379","author":"BJ Maron","year":"2018","unstructured":"Maron BJ (2018) Clinical course and management of hypertrophic cardiomyopathy. N Engl J Med 379:655\u2013668","journal-title":"N Engl J Med"},{"key":"2385_CR2","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","volume":"65","author":"C Semsarian","year":"2015","unstructured":"Semsarian C, Ingles J, Maron MS, Maron BJ (2015) New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol 65:1249\u20131254","journal-title":"J Am Coll Cardiol"},{"key":"2385_CR3","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1093\/eurheartj\/ehad581","volume":"44","author":"J Wang","year":"2023","unstructured":"Wang J, Yang S, Ma X et al (2023) Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines. Eur Heart J 44:4781\u20134792","journal-title":"Eur Heart J"},{"key":"2385_CR4","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.jacc.2024.02.014","volume":"83","author":"SR Ommen","year":"2024","unstructured":"Ommen SR, Ho CY, Asif IM et al (2024) 2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 83:2324\u20132405","journal-title":"J Am Coll Cardiol"},{"key":"2385_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1161\/CIRCULATIONAHA.122.063019","volume":"147","author":"E Monda","year":"2023","unstructured":"Monda E, Limongelli G (2023) Integrated sudden cardiac death risk prediction model for patients with hypertrophic cardiomyopathy. Circulation 147:281\u2013283","journal-title":"Circulation"},{"key":"2385_CR6","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.jacc.2018.05.060","volume":"72","author":"A Mentias","year":"2018","unstructured":"Mentias A, Raeisi-Giglou P, Smedira NG et al (2018) Late gadolinium enhancement in patients with hypertrophic cardiomyopathy and preserved systolic function. J Am Coll Cardiol 72:857\u2013870","journal-title":"J Am Coll Cardiol"},{"key":"2385_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.120.010489","volume":"13","author":"GD Aquaro","year":"2020","unstructured":"Aquaro GD, Grigoratos C, Bracco A et al (2020) Late gadolinium enhancement\u2013dispersion mapping: a new magnetic resonance imaging technique to assess prognosis in patients with hypertrophic cardiomyopathy and low-intermediate 5-year risk of sudden death. Circ Cardiovasc Imaging 13:e010489","journal-title":"Circ Cardiovasc Imaging"},{"key":"2385_CR8","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/ehjci\/jeaa423","volume":"22","author":"S Greulich","year":"2021","unstructured":"Greulich S, Seitz A, Herter D et al (2021) Long-term risk of sudden cardiac death in hypertrophic cardiomyopathy: a cardiac magnetic resonance outcome study. Eur Heart J Cardiovasc Imaging 22:732\u2013741","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2385_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.924804","volume":"9","author":"Y Chen","year":"2022","unstructured":"Chen Y, Zhao X, Yuan J, Zhang Y, Liu W, Qiao S (2022) Preoperative myocardial fibrosis is associated with worse survival after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: a delayed enhanced cardiac magnetic resonance study. Front Cardiovasc Med 9:924804","journal-title":"Front Cardiovasc Med"},{"key":"2385_CR10","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","volume":"44","author":"E Arbelo","year":"2023","unstructured":"Arbelo E, Protonotarios A, Gimeno JR et al (2023) 2023 ESC guidelines for the management of cardiomyopathies. Eur Heart J 44:3503\u20133626","journal-title":"Eur Heart J"},{"key":"2385_CR11","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jcmg.2022.10.020","volume":"16","author":"RE Jones","year":"2023","unstructured":"Jones RE, Zaidi HA, Hammersley DJ et al (2023) Comprehensive phenotypic characterization of late gadolinium enhancement predicts sudden cardiac death in coronary artery disease. JACC Cardiovasc Imaging 16:628\u2013638","journal-title":"JACC Cardiovasc Imaging"},{"key":"2385_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1161\/CIRCIMAGING.111.963819","volume":"5","author":"E Appelbaum","year":"2012","unstructured":"Appelbaum E, Maron BJ, Adabag S et al (2012) Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy. Circ Cardiovasc Imaging 5:78\u201385","journal-title":"Circ Cardiovasc Imaging"},{"key":"2385_CR13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.119.009156","volume":"12","author":"H Haghbayan","year":"2019","unstructured":"Haghbayan H, Lougheed N, Deva DP, Chan KK, Lima JA, Yan AT (2019) Peri-infarct quantification by cardiac magnetic resonance to predict outcomes in ischemic cardiomyopathy: prognostic systematic review and meta-analysis. Circ Cardiovasc Imaging 12:e009156","journal-title":"Circ Cardiovasc Imaging"},{"key":"2385_CR14","doi-asserted-by":"publisher","DOI":"10.1148\/ryct.210247","volume":"5","author":"T Shalmon","year":"2023","unstructured":"Shalmon T, Hamad FMD, Jimenez-Juan L et al (2023) Prognostic value of different thresholds for myocardial scar quantification on cardiac MRI late gadolinium enhancement images in patients receiving implantable cardioverter defibrillators. Radiol Cardiothorac Imaging 5:e210247","journal-title":"Radiol Cardiothorac Imaging"},{"key":"2385_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1532-429X-15-31","volume":"15","author":"H Rayatzadeh","year":"2013","unstructured":"Rayatzadeh H, Tan A, Chan RH et al (2013) Scar heterogeneity on cardiovascular magnetic resonance as a predictor of appropriate implantable cardioverter defibrillator therapy. J Cardiovasc Magn Reson 15:31","journal-title":"J Cardiovasc Magn Reson"},{"key":"2385_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12968-020-00610-6","volume":"22","author":"J Schulz-Menger","year":"2020","unstructured":"Schulz-Menger J, Bluemke DA, Bremerich J et al (2020) Standardized image interpretation and post-processing in cardiovascular magnetic resonance-2020 update: Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post-Processing. J Cardiovasc Magn Reson 22:19","journal-title":"J Cardiovasc Magn Reson"},{"key":"2385_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jacc.2014.12.018","volume":"66","author":"KA Hicks","year":"2015","unstructured":"Hicks KA, Tcheng JE, Bozkurt B et al (2015) 2014 ACC\/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). J Am Coll Cardiol 66:403\u2013469","journal-title":"J Am Coll Cardiol"},{"key":"2385_CR18","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","volume":"35","author":"C O\u2019Mahony","year":"2014","unstructured":"O\u2019Mahony C, Jichi F, Pavlou M et al (2014) A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart J 35:2010\u20132020","journal-title":"Eur Heart J"},{"key":"2385_CR19","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","volume":"130","author":"RH Chan","year":"2014","unstructured":"Chan RH, Maron BJ, Olivotto I et al (2014) Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation 130:484\u2013495","journal-title":"Circulation"},{"key":"2385_CR20","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.jcmg.2016.02.031","volume":"9","author":"Z Weng","year":"2016","unstructured":"Weng Z, Yao J, Chan RH et al (2016) Prognostic value of LGE-CMR in HCM: a meta-analysis. JACC Cardiovasc Imaging 9:1392\u20131402","journal-title":"JACC Cardiovasc Imaging"},{"key":"2385_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jcmg.2023.07.005","volume":"17","author":"A Kiaos","year":"2024","unstructured":"Kiaos A, Daskalopoulos GN, Kamperidis V, Ziakas A, Efthimiadis G, Karamitsos TD (2024) Quantitative late gadolinium enhancement cardiac magnetic resonance and sudden death in hypertrophic cardiomyopathy: a meta-analysis. JACC Cardiovasc Imaging 17:489\u2013497","journal-title":"JACC Cardiovasc Imaging"},{"key":"2385_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-52058-8","volume":"14","author":"L Jada","year":"2024","unstructured":"Jada L, Holtackers RJ, Martens B et al (2024) Quantification of myocardial scar of different etiology using dark- and bright-blood late gadolinium enhancement cardiovascular magnetic resonance. Sci Rep 14:5395","journal-title":"Sci Rep"},{"key":"2385_CR23","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1007\/s00330-017-4869-x","volume":"27","author":"M Avanesov","year":"2017","unstructured":"Avanesov M, M\u00fcnch J, Weinrich J et al (2017) Prediction of the estimated 5-year risk of sudden cardiac death and syncope or non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy using late gadolinium enhancement and extracellular volume CMR. Eur Radiol 27:5136\u20135145","journal-title":"Eur Radiol"},{"key":"2385_CR24","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1136\/heartjnl-2013-305471","volume":"100","author":"TF Ismail","year":"2014","unstructured":"Ismail TF, Jabbour A, Gulati A et al (2014) Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy. Heart 100:1851\u20131558","journal-title":"Heart"},{"key":"2385_CR25","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.jacc.2009.01.056","volume":"53","author":"KH Schuleri","year":"2009","unstructured":"Schuleri KH, Centola M, George RT et al (2009) Characterization of peri-infarct zone heterogeneity by contrast-enhanced multidetector computed tomography: a comparison with magnetic resonance imaging. J Am Coll Cardiol 53:1699\u20131707","journal-title":"J Am Coll Cardiol"},{"key":"2385_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.722340","volume":"8","author":"Z Cheng","year":"2021","unstructured":"Cheng Z, Fang T, Huang J, Guo Y, Alam M, Qian H (2021) Hypertrophic cardiomyopathy: from phenotype and pathogenesis to treatment. Front Cardiovasc Med 8:722340","journal-title":"Front Cardiovasc Med"},{"key":"2385_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/jcdd12030101","volume":"12","author":"A Kasiakogias","year":"2025","unstructured":"Kasiakogias A, Kaskoutis C, Antoniou C-K et al (2025) Exploring the current status of risk stratification in hypertrophic cardiomyopathy: from risk models to promising techniques. J Cardiovasc Dev Dis 12:101","journal-title":"J Cardiovasc Dev Dis"},{"key":"2385_CR28","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.jcmg.2023.03.011","volume":"16","author":"S Yang","year":"2023","unstructured":"Yang S, Zhao K, Yang K et al (2023) Subendocardial involvement as an underrecognized LGE subtype related to adverse outcomes in hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 16:1163\u20131177","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-026-02385-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-026-02385-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-026-02385-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:47:31Z","timestamp":1787752051000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13244-026-02385-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2385"],"URL":"https:\/\/doi.org\/10.1186\/s13244-026-02385-3","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the Ethics Board of Beijing Anzhen Hospital (No.: 2025186x). The requirement for written informed consent was waived owing to the study\u2019s retrospective nature.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for informed consent was waived due to the retrospective nature of the study.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"210"}}